| RS2548068889 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548068894 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548068920 |
PEX7
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Rhizomelic chondrodysplasia punctata type 1 |
| RS2548071249 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548072023 |
PEX7
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Rhizomelic chondrodysplasia punctata type 1 |
| RS2548072028 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Rhizomelic chondrodysplasia punctata type 1 |
| RS2548072047 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548072133 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548072160 |
PEX7
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Rhizomelic chondrodysplasia punctata type 1 |
| RS2548072230 |
PEX7
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Rhizomelic chondrodysplasia punctata type 1 |
| RS2548082631 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548082658 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548082672 |
PEX7
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Rhizomelic chondrodysplasia punctata type 1 |
| RS2548082731 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548082750 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548090655 |
MAPK8IP3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without variable brain abnormalities, NEDBA |
| RS2548095304 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548095308 |
PEX7
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Rhizomelic chondrodysplasia punctata type 1 |
| RS2548095325 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548095371 |
PEX7
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Rhizomelic chondrodysplasia punctata type 1 |
| RS2548095379 |
PEX7
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Peroxisome biogenesis disorder 9B |
| RS2548095417 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548095423 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548096558 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548096639 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Rhizomelic chondrodysplasia punctata type 1 |
| RS2548105720 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS2548108996 |
PPP1R12A
|
Health Risk |
Likely pathogenic |
Genitourinary and/or brain malformation syndrome, Genitourinary and/or brain malformation syndrome |
| RS2548112862 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548112881 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548112960 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548113260 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548113423 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548113928 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548116564 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS2548119843 |
STAC3
|
Health Risk |
Pathogenic |
Bailey-Bloch congenital myopathy, Bailey-Bloch congenital myopathy |
| RS2548120498 |
VPS13C
|
Health Risk |
Likely pathogenic |
— |
| RS2548121140 |
STAC3
|
Health Risk |
Pathogenic |
Bailey-Bloch congenital myopathy, Bailey-Bloch congenital myopathy |
| RS2548122686 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548123187 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548125094 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS2548140072 |
EPB41
|
Health Risk |
Likely pathogenic |
Elliptocytosis 1, Elliptocytosis 1 |
| RS2548142680 |
PCCA
|
Health Risk |
Pathogenic |
PCCA-related disorder, PCCA-related disorder |
| RS2548142725 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548142802 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548143083 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548144366 |
SCAPER
|
Health Risk |
Likely pathogenic |
SCAPER-related disorder, SCAPER-related disorder |
| RS2548147835 |
VPS13C
|
Health Risk |
Pathogenic |
— |
| RS2548148441 |
SOX5
|
Health Risk |
Pathogenic |
— |
| RS2548154497 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548154517 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548157942 |
IGFALS
|
Health Risk |
Likely pathogenic |
Short stature due to primary acid-labile subunit deficiency, Short stature due to primary acid-labile subunit deficiency |
| RS2548164806 |
MEF2C
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS2548168192 |
KCNC2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 103, Developmental and epileptic encephalopathy 103 |
| RS2548168565 |
MEF2C
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2548180428 |
EPB41
|
Health Risk |
Pathogenic/Likely pathogenic |
EPB41-related disorder, Elliptocytosis 1 |
| RS2548185457 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548185516 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548185517 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548185540 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS2548185737 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548185743 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548185752 |
GNPTG
|
Health Risk |
Likely pathogenic |
— |
| RS2548185876 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548189355 |
GNPTG
|
Health Risk |
Likely pathogenic |
— |
| RS2548189368 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548189385 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548189390 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS2548189596 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548189633 |
GNPTG
|
Health Risk |
Likely pathogenic |
— |
| RS2548189836 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548189846 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548189890 |
GNPTG
|
Health Risk |
Pathogenic/Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS2548190056 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548190157 |
GNPTG
|
Health Risk |
Likely pathogenic |
— |
| RS2548190448 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS2548190467 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS2548190486 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548190488 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548190647 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548190655 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2548195978 |
MEIOB
|
Health Risk |
Pathogenic |
Spermatogenic failure 22, Spermatogenic failure 22 |
| RS2548199661 |
DOCK3
|
Health Risk |
Likely pathogenic |
DOCK3-related disorder, DOCK3-related disorder |
| RS2548206668 |
SLX4
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548207397 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548211131 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548211210 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548211710 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548211822 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548213278 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548214240 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548216361 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548217212 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548217715 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548218058 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548218922 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548218961 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548219251 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2548221544 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2548222345 |
SLX4
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group P, Fanconi anemia complementation group P |
| RS2548224341 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |